Stock SPARC SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Sun Pharma Advanced Research Company Limited

Equities

SPARC

INE232I01014

Pharmaceuticals

Market Closed - NSE India S.E.
Other stock markets
 07:42:31 2024-04-30 am EDT 		5-day change 1st Jan Change
232.3 INR -4.99% Intraday chart for Sun Pharma Advanced Research Company Limited -26.48% -19.00%
Apr. 15 Transcript : Sun Pharma Advanced Research Company Limited - Special Call
Apr. 10 Sun Pharma Advanced Research Company Limited Announces Results from the Planned Interim Analysis of the PROSEEK Study of Vodobatinib in Patients with Early Parkinson's Disease CI

Business Summary

Sun Pharma Advanced Research Company Limited is an India-based clinical-stage bio-pharmaceutical company. The Company is in the business of research and development (R&D) of pharmaceutical products to unmet medical needs in the areas of oncology, neurodegeneration and immunology. The Company develops New Chemical Entities (NCE), New Biological Entities and reformulated products. Its NCE includes SCC-138, SCO-088, SCO-120 and SCD-044. Its Novel Drug Delivery Systems (NDDS) include Wrap Matrix Technology, Lipexelle technology and TearAct Technology. Wrap Matrix technology is useful to develop controlled release tablets. It has developed Elepsia XR using Wrap MatrixTM technology. Lipexelle technology for ophthalmic formulations. It has also developed Xelpros, a BAK free latanoprost eye drop developed using Lipexelle technology. Xelpros is commercialized by its partner in the United States. It has also developed PDP-716 eye drops for treatment of Glaucoma based on its TearAct technology.

Number of employees: 407

Sales per Business

INR in Million2022Weight2023Weight Delta
Pharmaceuticals Research and Development
100.0 %
1,372 100.0 % 2,388 100.0 % +73.98%

Sales per region

INR in Million2022Weight2023Weight Delta
International
55.2 %
50 3.7 % 1,317 55.2 % +2,523.59%
India
44.8 %
1,322 96.3 % 1,071 44.8 % -19.03%

Managers

Managers TitleAgeSince
Anilkumar Raghavan CEO
 Chief Executive Officer 54 14-04-23
Chetan Rajpara DFI
 Director of Finance/CFO - 17-01-31
Dilip Shantilal Shanghvi CHM
 Chairman 68 06-02-28
Siu-Long Yao COO
 Chief Operating Officer - 14-10-31
Kajal Damania CMP
 Compliance Officer - 23-09-21
Rajamannar Thennati BRD
 Director/Board Member 63 07-06-03
Sudhir Vrundavandas Valia BRD
 Director/Board Member 67 06-02-28
Jaydeep Issrani IRC
 Investor Relations Contact - -
Nitin Damle PRN
 Corporate Officer/Principal - 22-03-31
Shanta Gupta HRO
 Human Resources Officer - -

Members of the board

Members of the board TitleAgeSince
Dilip Shantilal Shanghvi CHM
 Chairman 68 06-02-28
Sudhir Vrundavandas Valia BRD
 Director/Board Member 67 06-02-28
Bhavna Gautam Doshi BRD
 Director/Board Member 70 14-10-30
Robert Spiegel BRD
 Director/Board Member 73 20-05-31
Rajamannar Thennati BRD
 Director/Board Member 63 07-06-03
Ferzaan Engineer BRD
 Director/Board Member 61 17-05-04

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 324,521,588 82,408,699 ( 25.39 %) 0 25.39 %

Shareholders

NameEquities%Valuation
Shanghvi Finance Pvt Ltd.
43.79 %
142,099,913 43.79 % 630 M ₹
Dilip Shantilal Shanghvi
19.05 %
61,810,660 19.05 % 274 M ₹
Sun Pharmaceutical Industries Key Employees Benefit Trust
3.179 %
10,317,377 3.179 % 46 M ₹
Rekha Rakesh Jhunjhunwala
1.939 %
6,292,134 1.939 % 28 M ₹
Lakshdeep Investments & Finance Pvt Ltd.
1.565 %
5,080,142 1.565 % 23 M ₹
Raksha Sudhir Valia
1.277 %
4,145,231 1.277 % 18 M ₹
Mohanlal Vijay Parekh
1.128 %
3,661,304 1.128 % 16 M ₹
Paresh Mohanlal Parekh
1.124 %
3,646,837 1.124 % 16 M ₹
Sudhir Vrundavandas Valia
0.5651 %
1,833,951 0.5651 % 8 M ₹
Unimed Investments Ltd.
0.3907 %
1,267,963 0.3907 % 6 M ₹

Company contact information

Sun Pharma Advanced Research Co. Ltd.

Mahal Industrial Estate Mahakali Caves Road

400093, Mumbai

+91 22 6645 5645

http://www.sparc.life
address Sun Pharma Advanced Research Company Limited(SPARC)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED Stock Sun Pharma Advanced Research Company Limited
-19.00% 951M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+33.73% 664B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.29% 567B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.57% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.45% 330B
ABBVIE INC. Stock AbbVie Inc.
+4.81% 286B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.79% 234B
NOVARTIS AG Stock Novartis AG
+4.93% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-9.78% 196B
AMGEN INC. Stock Amgen Inc.
-4.38% 148B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. SPARC Stock
  4. Company Sun Pharma Advanced Research Company Limited